| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BOLD | Boundless Bio, Inc. | CRANDELL KEITH | 10% Owner | Apr 02, 2024 | Buy | $16.00 | 200,000 | 3,200,000 | 1,181,766 | Apr 04, 2024, 04:30 PM | |
| PRME | Prime Medicine, Inc. | CRANDELL KEITH | 10% Owner | Feb 15, 2024 | Buy | $6.25 | 3,200,000 | 20,000,000 | 3,200,000 | Feb 20, 2024, 05:37 PM | |
| SANA | Sana Biotechnology, Inc. | CRANDELL KEITH | 10% Owner | Feb 08, 2024 | Buy | $5.50 | 1,818,181 | 9,999,996 | 12,446,022 | Feb 12, 2024, 05:43 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Nov 14, 2023 | Buy | $11.98 | 3,357 | 40,217 | 4,131,207 | Nov 15, 2023, 06:54 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Nov 13, 2023 | Buy | $11.75 | 31,653 | 371,923 | 4,127,850 | Nov 15, 2023, 06:54 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Nov 08, 2023 | Buy | $11.03 | 92,251 | 1,017,821 | 4,047,843 | Nov 13, 2023, 07:00 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Nov 09, 2023 | Buy | $10.53 | 31,079 | 327,262 | 4,078,922 | Nov 13, 2023, 07:00 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Nov 10, 2023 | Buy | $11.49 | 17,275 | 198,481 | 4,096,197 | Nov 13, 2023, 07:00 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Nov 07, 2023 | Buy | $11.50 | 30,192 | 347,208 | 3,955,592 | Nov 07, 2023, 06:59 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Nov 03, 2023 | Buy | $11.38 | 22,420 | 255,140 | 3,882,318 | Nov 07, 2023, 06:59 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Nov 06, 2023 | Buy | $11.55 | 43,082 | 497,597 | 3,925,400 | Nov 07, 2023, 06:59 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Sep 28, 2023 | Buy | $13.44 | 41,951 | 563,699 | 3,825,338 | Sep 29, 2023, 06:53 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Sep 29, 2023 | Buy | $13.98 | 34,560 | 483,149 | 3,859,898 | Sep 29, 2023, 06:53 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Sep 27, 2023 | Buy | $12.31 | 24,504 | 301,644 | 3,783,387 | Sep 27, 2023, 08:18 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Sep 26, 2023 | Buy | $11.73 | 34,000 | 398,820 | 3,758,883 | Sep 27, 2023, 08:18 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Sep 22, 2023 | Buy | $11.14 | 40,000 | 445,600 | 3,664,143 | Sep 25, 2023, 09:38 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Sep 25, 2023 | Buy | $11.22 | 60,740 | 681,464 | 3,724,883 | Sep 25, 2023, 09:38 PM | |
| NMRA | Neumora Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Sep 19, 2023 | Buy | $17.00 | 1,500,000 | 25,500,000 | 3,624,143 | Sep 20, 2023, 06:16 AM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Apr 03, 2023 | Option Exercise | $11.16 | 1,170 | 13,057 | 131,236 | Apr 04, 2023, 06:23 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Jan 03, 2023 | Option Exercise | $12.86 | 1,015 | 13,053 | 130,066 | Jan 04, 2023, 04:03 PM | |
| PRME | Prime Medicine, Inc. | CRANDELL KEITH | 10% Owner | Oct 24, 2022 | Buy | $17.00 | 400,000 | 6,800,000 | 6,128,297 | Oct 26, 2022, 08:01 PM | |
| PRME | Prime Medicine, Inc. | CRANDELL KEITH | 10% Owner | Oct 24, 2022 | Buy | $17.00 | 400,000 | 6,800,000 | 6,128,297 | Oct 26, 2022, 08:01 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Oct 03, 2022 | Option Exercise | $10.48 | 1,326 | 13,896 | 120,968 | Oct 05, 2022, 04:04 PM | |
| CDAK | Codiak BioSciences, Inc. | CRANDELL KEITH | 10% Owner | Sep 13, 2022 | Buy | $1.50 | 5,000,000 | 7,500,000 | 8,854,098 | Sep 15, 2022, 06:53 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Jul 01, 2022 | Option Exercise | $16.79 | 893 | 14,993 | 119,642 | Jul 06, 2022, 04:07 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Apr 01, 2022 | Option Exercise | $30.47 | 492 | 14,991 | 118,749 | Apr 05, 2022, 04:42 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Jan 03, 2022 | Option Exercise | $42.41 | 307 | 13,020 | 118,257 | Jan 05, 2022, 04:06 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Oct 01, 2021 | Option Exercise | $51.18 | 254 | 13,000 | 96,012 | Oct 05, 2021, 04:02 PM | |
| TWST | Twist Bioscience Corp | CRANDELL KEITH | Director | Aug 12, 2021 | Sale | $106.93 | 1,412 | 150,985 | 486 | Aug 13, 2021, 06:35 PM | |
| TWST | Twist Bioscience Corp | CRANDELL KEITH | Director | Aug 12, 2021 | Sale | $107.01 | 43,588 | 4,664,413 | 78,602 | Aug 13, 2021, 06:35 PM | |
| DALS | DA32 Life Science Tech Acquisition Corp. | CRANDELL KEITH | Director | Jul 30, 2021 | Buy | $10.00 | 1,600,000 | 16,000,000 | 1,600,000 | Aug 03, 2021, 09:12 PM | |
| DALS | DA32 Life Science Tech Acquisition Corp. | CRANDELL KEITH | Director | Jul 30, 2021 | Option Exercise | $10.00 | 650,000 | 6,500,000 | 2,250,000 | Aug 03, 2021, 09:12 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Jul 01, 2021 | Option Exercise | $59.48 | 218 | 12,967 | 75,852 | Jul 06, 2021, 05:17 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Apr 01, 2021 | Option Exercise | $61.45 | 211 | 12,966 | 41,924 | Jul 06, 2021, 05:17 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Apr 01, 2021 | Option Exercise | $61.45 | 211 | 12,966 | 14,637 | Apr 02, 2021, 09:43 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Jan 04, 2021 | Option Exercise | $44.11 | 197 | 8,690 | 14,426 | Jan 05, 2021, 06:04 PM | |
| MASS | 908 Devices Inc. | CRANDELL KEITH | Director | Dec 22, 2020 | Buy | $20.00 | 300,000 | 6,000,000 | 5,725,045 | Dec 22, 2020, 08:17 PM | |
| TWST | Twist Bioscience Corp | CRANDELL KEITH | Director | Dec 07, 2020 | Sale | $103.40 | 53,712 | 5,553,821 | 726,834 | Dec 09, 2020, 05:11 PM | |
| TWST | Twist Bioscience Corp | CRANDELL KEITH | Director | Dec 07, 2020 | Sale | $103.40 | 21,288 | 2,201,179 | 288,104 | Dec 09, 2020, 05:11 PM | |
| CDAK | Codiak BioSciences, Inc. | CRANDELL KEITH | 10% Owner | Oct 16, 2020 | Buy | $15.00 | 235,000 | 3,525,000 | 2,503,903 | Oct 20, 2020, 08:07 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Oct 01, 2020 | Option Exercise | $34.70 | 338 | 11,729 | 10,071 | Oct 05, 2020, 06:12 PM | |
| MTCR | Metacrine, Inc. | CRANDELL KEITH | 10% Owner | Sep 18, 2020 | Buy | $13.00 | 230,000 | 2,990,000 | 2,781,769 | Sep 22, 2020, 11:07 AM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Jul 01, 2020 | Option Exercise | $27.80 | 422 | 11,732 | 9,733 | Jul 06, 2020, 04:10 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Apr 01, 2020 | Option Exercise | $19.21 | 611 | 11,737 | 9,311 | Apr 03, 2020, 04:27 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Jan 02, 2020 | Option Exercise | $23.12 | 508 | 11,745 | 8,700 | Jan 06, 2020, 04:04 PM | |
| VIR | Vir Biotechnology, Inc. | CRANDELL KEITH | 10% Owner | Oct 16, 2019 | Buy | $20.00 | 1,000,000 | 20,000,000 | 1,000,000 | Oct 18, 2019, 07:54 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Oct 01, 2019 | Option Exercise | $21.41 | 548 | 11,733 | 5,922 | Oct 03, 2019, 04:10 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | CRANDELL KEITH | 10% Owner | Jul 15, 2019 | Sale | $8.27 | 2,700 | 22,316 | 4,302,051 | Jul 17, 2019, 07:26 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | CRANDELL KEITH | 10% Owner | Jul 16, 2019 | Sale | $7.81 | 25,779 | 201,277 | 4,276,572 | Jul 17, 2019, 07:26 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | CRANDELL KEITH | 10% Owner | Jul 17, 2019 | Sale | $7.70 | 34,521 | 265,687 | 4,242,051 | Jul 17, 2019, 07:26 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Jul 01, 2019 | Option Exercise | $35.38 | 332 | 11,746 | 5,374 | Jul 03, 2019, 03:25 PM | |
| KRTX | Karuna Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Jul 02, 2019 | Buy | $16.00 | 200,000 | 3,200,000 | 100,000 | Jul 02, 2019, 05:09 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Apr 01, 2019 | Option Exercise | $23.40 | 502 | 11,747 | 5,042 | Apr 03, 2019, 06:12 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | CRANDELL KEITH | 10% Owner | Mar 12, 2019 | Sale | $7.37 | 40,092 | 295,374 | 4,432,462 | Mar 14, 2019, 06:57 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | CRANDELL KEITH | 10% Owner | Mar 13, 2019 | Sale | $7.90 | 84,411 | 666,565 | 4,350,871 | Mar 14, 2019, 06:57 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | CRANDELL KEITH | 10% Owner | Mar 14, 2019 | Sale | $8.15 | 43,000 | 350,441 | 4,305,051 | Mar 14, 2019, 06:57 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | CRANDELL KEITH | 10% Owner | Mar 07, 2019 | Sale | $6.87 | 35,209 | 242,013 | 4,601,928 | Mar 11, 2019, 05:58 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | CRANDELL KEITH | 10% Owner | Mar 08, 2019 | Sale | $6.93 | 84,496 | 585,270 | 4,517,432 | Mar 11, 2019, 05:58 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | CRANDELL KEITH | 10% Owner | Mar 11, 2019 | Sale | $6.49 | 44,878 | 291,366 | 4,472,554 | Mar 11, 2019, 05:58 PM | |
| SNNA | Sienna Biopharmaceuticals, Inc. | CRANDELL KEITH | 10% Owner | Feb 22, 2019 | Buy | $2.50 | 2,165,800 | 5,414,500 | 2,900,575 | Feb 26, 2019, 09:08 PM | |
| SNNA | Sienna Biopharmaceuticals, Inc. | CRANDELL KEITH | 10% Owner | Feb 22, 2019 | Buy | $2.50 | 2,165,800 | 5,414,500 | 2,900,575 | Feb 26, 2019, 09:06 PM | |
| TWST | Twist Bioscience Corp | CRANDELL KEITH | Director | Nov 02, 2018 | Buy | $14.00 | 75,000 | 1,050,000 | 2,407,422 | Nov 06, 2018, 05:00 PM | |
| QTRX | Quanterix Corp | CRANDELL KEITH | Director | Dec 11, 2017 | Buy | $15.00 | 266,000 | 3,990,000 | 1,537,684 | Dec 13, 2017, 04:24 PM | |
| PI | IMPINJ INC | CRANDELL KEITH | 10% Owner | Jul 26, 2016 | Option Exercise | $9.73 | 61,338 | 596,969 | 1,388,048 | Aug 30, 2016, 09:51 PM | |
| PI | IMPINJ INC | CRANDELL KEITH | 10% Owner | Jul 26, 2016 | Option Exercise | $11.19 | 66,667 | 746,016 | 1,388,049 | Jul 26, 2016, 07:51 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | CRANDELL KEITH | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 4,637,137 | Jul 07, 2016, 06:02 AM | |
| PZRX | PHASERX, INC. | CRANDELL KEITH | 10% Owner | May 23, 2016 | Sale | $2.98 | 1,680,059 | 5,006,801 | 2,854,222 | May 25, 2016, 05:44 PM | |
| XCOM | XTERA COMMUNICATIONS, INC. | CRANDELL KEITH | 10% Owner | Nov 17, 2015 | Buy | $5.00 | 300,000 | 1,500,000 | 1,885,090 | Nov 18, 2015, 07:55 PM | |
| IOTS | ADESTO TECHNOLOGIES Corp | CRANDELL KEITH | Director | Oct 26, 2015 | Buy | $5.00 | 400,000 | 2,000,000 | 400,000 | Oct 28, 2015, 05:07 PM | |
| IOTS | ADESTO TECHNOLOGIES Corp | CRANDELL KEITH | Director | Oct 26, 2015 | Buy | $5.00 | 400,000 | 2,000,000 | 400,000 | Oct 28, 2015, 05:07 PM | |
| VBIV | VBI VACCINES INC. | CRANDELL KEITH | 10% Owner | Aug 13, 2015 | Option Exercise | $2.10 | 650,000 | 1,365,000 | 4,047,830 | Aug 17, 2015, 07:52 PM | |
| PULM | Pulmatrix, Inc. | CRANDELL KEITH | 10% Owner | Jun 16, 2015 | Buy | $6.88 | 72,750 | 500,156 | 2,286,456 | Jun 17, 2015, 08:29 PM | |
| BLPH | Bellerophon Therapeutics, Inc. | CRANDELL KEITH | 10% Owner | Feb 19, 2015 | Buy | $12.00 | 212,666 | 2,551,992 | 965,660 | Feb 23, 2015, 09:48 PM | |
| RCPT | Receptos, Inc. | CRANDELL KEITH | 10% Owner | May 13, 2014 | Sale | $29.95 | 36,986 | 1,107,572 | 2,091,363 | May 15, 2014, 07:55 PM | |
| RCPT | Receptos, Inc. | CRANDELL KEITH | 10% Owner | May 14, 2014 | Sale | $28.39 | 8,395 | 238,334 | 2,058,634 | May 15, 2014, 07:55 PM | |
| FATE | FATE THERAPEUTICS INC | CRANDELL KEITH | 10% Owner | Oct 04, 2013 | Option Exercise | $6.00 | 961,780 | 5,770,680 | 2,473,188 | Oct 07, 2013, 02:06 PM | |
| RCPT | Receptos, Inc. | CRANDELL KEITH | 10% Owner | May 14, 2013 | Buy | $14.00 | 284,485 | 3,982,790 | 2,101,376 | May 14, 2013, 05:33 PM | |
| KYTH | KYTHERA BIOPHARMACEUTICALS INC | CRANDELL KEITH | 10% Owner | Oct 16, 2012 | Option Exercise | $10.94 | 168,149 | 1,839,985 | 2,152,006 | Oct 16, 2012, 02:35 PM | |
| NGSX | NeurogesX Inc | CRANDELL KEITH | 10% Owner | Jul 21, 2011 | Buy | $1.65 | 1,744,186 | 2,877,907 | 4,187,777 | Jul 25, 2011, 09:09 PM |
Menu